Mizuki Onozawa

7PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 14, 2026
Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real-World Data From Japan.

|Aug 06, 2026
Deferred Cytoreductive Nephrectomy With Partial Hepatectomy for Giant Renal Cell Carcinoma of the Right Kidney With Extensive Hepatic Invasion: A Case Report in the Era of Systemic Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.

|Jul 06, 2023
A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy.

Satoru Taguchi, Mizuki Onozawa, Shiro Hinotsu

|Sep 23, 2022
Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan.

Kozaburo Tanuma, Koji Kawai, Satoshi Nitta

|Mar 19, 2021
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.

Jasmine Lim, Mizuki Onozawa, Marniza Saad

|Oct 24, 2020
Modified J-CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy.

Jasmine Lim, Shiro Hinotsu, Mizuki Onozawa

Pageof 2

Frequent Collaborators

3 joint publications

Jun Miyazaki

2 joint publications

Jasmine Lim

2 joint publications

Teng-Aik Ong

2 joint publications

Satoru Taguchi